You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 16, September 12, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Genetics
 •Genetic Disorders
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Practicing Medicine at the Front Lines of the Genomic Revolution

Arch Intern Med. 2005;165:1815-1817.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

There is unequivocal evidence that most common illnesses, such as coronary atherosclerosis, diabetes, many cancers, obesity, and certain psychiatric diseases (eg, schizophrenia), are due to interactions between multiple genetic and environmental factors. While humans are 99.9% genetically alike, the dissimilarities of the remaining 0.1% of the human genome contribute importantly to the occurrence of human disease. These differences are composed of about 10 million common variants (present in 1% or more of alleles) and many more rare variants. Numerous reports have implicated genetic variations in the propensity toward (or resistance to) illness and the response to medical treatment. There has been considerable success in the use of genomics for mendelian disorders such as cystic fibrosis, Huntington disease, and hereditary breast-ovarian cancer (BRCA1 and BRCA2). However, many of the most common disorders lack simple mendelian inheritance and are impacted by multiple genetic events along with complex nongenetic modulators (eg, . . . [Full Text of this Article]


AUTHOR INFORMATION
Wendy S. Rubinstein, MD, PhD; Hemant K. Roy, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Genetic Liability to Fractures in the Elderly
Karl Michaëlsson, Håkan Melhus, Helene Ferm, Anders Ahlbom, and Nancy L. Pedersen
Arch Intern Med. 2005;165(16):1825-1830.
ABSTRACT | FULL TEXT  

Prediction of Progression to Cirrhosis by a Glutathione S-Transferase P1 Polymorphism in Subjects With Hereditary Hemochromatosis
Felix Stickel, Christoph H. Österreicher, Christian Datz, Peter Ferenci, Marco Wölfel, Wolfgang Norgauer, Michael R. Kraus, Fritz Wrba, Claus Hellerbrand, and Detlef Schuppan
Arch Intern Med. 2005;165(16):1835-1840.
ABSTRACT | FULL TEXT  

Ready for Genomic Medicine? Perspectives of Health Care Decision Makers
Paul R. Billings, Rick J. Carlson, Josh Carlson, Mary Cain, Charles Wilson, Peter Shorett, and Wendy Everett
Arch Intern Med. 2005;165(16):1917-1919.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Screening for hemochromatosis in asymptomatic subjects with or without a family history.
Powell et al.
Arch Intern Med 2006;166:294-301.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.